Share the Science: Dr Yago Nieto - Potential Cost-Saving Therapy for Lymphoma

Save the Cord Foundation and WellSky are proud to welcome Dr. Yago Nieto from The University of Texas MD Anderson Cancer Center as our featured speaker for the next edition of Share the Science.

Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. ​Learn more about this exciting educational series here.

Can we open the door to low cost cancer treatments with cord blood?

We are thrilled to welcome back Dr. Yago Nieto (MD Anderson Cancer Center) to speak about his recently published study focused on novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody. This could open the door to new low-cost cancer treatment and cord blood is key!

For this presentation, Dr. Nieto will discuss his latest research using cord blood: "Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial" ( https://www.nature.com/articles/s41591-025-03640-8 ). 
​
Natural killer (NK) cells are key elements of the immune system, with a crucial role in eradicating cells that have become malignant or infected with a virus. Cord blood constitutes an important source of NK cells, which then require a complex process of activation, manufacturing, and expansion in the lab prior to infusion to patients with cancer. Our group has developed off-the-shelf frozen cord blood-derived NK cells that we have tested in a variety of cancers with encouraging results.  
 
Learning objectives:

1. To discuss the mechanism of action of natural killer (NK) cells and their source for treatment of cancer.
2. To analyze the main results of studies of donor NK cell therapy, focusing on those studies using banked cord blood as source.
3. To review future lines of progress.

SHARE THE SCIENCE
with
Dr. Yago Nieto 

​The University of Texas MD Anderson Cancer Center
Department of Stem Cell Transplantation
 
"Umbilical Cord Blood-Derived
Novel Cellular Therapies for Lymphomas" 
Free webinar.  Open to the public.
​
Friday, January 30th at 1pm US Eastern Time / 12 noon US Central Time

Click here to register free : Webinar with Dr Yago Nieto

About the speaker

Yago L. Nieto, MD, PhD
​MD Anderson Cancer Center

Yago Nieto, MD, PhD, is a Professor of Medicine at The University of Texas MD Anderson Cancer Center in the Department of Stem Cell Transplantation and Cellular Therapy. He is a stem-cell transplant specialist with 25 years of experience in the field. His research focus is the development of novel chemotherapy regimens for use in autologous and allogeneic transplantation for lymphomas and the introduction of novel therapeutics.

Dr. Nieto is the PI of numerous investigator-initiated clinical trials. He serves as the Co-Chairman of the Myeloma Working Group & Solid Tumor Working Group for the Center for International Blood and Marrow Transplant Research (CIBMTR).

​Dr. Nieto has received numerous awards throughout his career including America’s Top Physician and Mentor of the Year Award at MD Anderson Cancer Center.